ENTPD1/CD39 is a promising therapeutic target in oncology.
Autor: | Bastid, J1, Cottalorda-Regairaz, A1, Alberici, G1, Bonnefoy, N2, Eliaou, J-F3, Bensussan, A4 |
---|---|
Zdroj: | Oncogene. 4/4/2013, Vol. 32 Issue 14, p1743-1751. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |